Riskpilot← Back to searchSign inGet full accessAHC Medical AB
ABActiveOrg 5568489743Wallingatan 30Medical specialists activities · NACE 8622Est. 20115-9 employees
Revenue 2024
SEK 19,1M
+1% vs 2023
EBITDA margin
9.1%
-8% vs 2023
Equity ratio
5.4%
Financial strength
Net profit 2024
SEK -20K
-110% vs 2023
| Revenue | SEK 19,1M | +1% |
| EBITDA | SEK 1,7M | -8% |
| Net profit | SEK -20K | -110% |
| Total assets | SEK 5,1M | -23% |
| Equity | SEK 279K | -44% |
| Employees | — | — |
Legal name
AHC Medical AB
Org number
5568489743
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
7 april 2011
Share capital
SEK 50 000
Employees
5-9
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolaget ska bedriva mottagning och operationsverksamhet inom sjukvård och friskvård samt därmed förenlig verksamhet.
Address
Wallingatan 30
Email
fredrik.skog@aktivmedicin.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 424 | 8 031 | 18 623 | 18 923 | 19 140 |
| Staff expenses | — | — | — | −6 674 | −6 558 |
| EBITDA | −138 | 1 301 | 2 017 | 1 895 | 1 746 |
| Depreciation & amort. | −28 | −670 | −933 | −719 | −743 |
| EBIT | −166 | 631 | 1 084 | 1 176 | 1 003 |
| Net financials | −90 | −103 | −109 | −82 | −50 |
| Profit before tax | −256 | 471 | 975 | 295 | 1 |
| Tax | −0 | −43 | −201 | −90 | −21 |
| Net profit | −256 | 428 | 774 | 205 | −20 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 7 152 | 6 729 | 7 167 | 6 661 | 5 143 |
| Equity | 87 | 516 | 1 290 | 495 | 279 |
| Long-term debt | 2 850 | 5 708 | 979 | 250 | — |
| Short-term debt | 4 214 | 447 | 4 840 | 5 859 | 4 805 |
| Total debt | 7 064 | 6 155 | 5 819 | 6 109 | 4 805 |
EBITDA margin
9.1%
This company
15.8%
Market median
-42% vs market
20202024
Equity ratio
5.4%
This company
38.2%
Market median
-86% vs market
20202024
Return on equity
-7.2%
This company
18.4%
Market median
-139% vs market
20202024
Net profit margin
-0.1%
This company
8.1%
Market median
-101% vs market
20202024
Asset turnover
3.72×
This company
1.12×
Market median
+232% vs market
20202024
Debt / equity
17.40×
This company
0.62×
Market median
-2706% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-09-01 – 2020-08-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
GF Chief Executive Officer | Chief Executive Officer | 2022 |
LK Audit | Audit | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2025 | |
| Chairman | 2022 | |
| Former (1) | ||
| Board of Directors | 2024 – 2025 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Forrest Capital AB
AHC Medical AB Board members of AHC Medical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Göran Fredrik Skog | Chief Executive Officer | 0 companies |
| Lars Kenneth Elton | Audit | 0 companies |
| Inger Agneta Ledin Skog | Deputy Board Member | 0 companies |
| Göran Rune Skog | Chairman | 0 companies |
| Linn Josephine Barnickel | Board of Directors | 0 companies |